Clorazepate: double blind crossover comparison of a single nightly dose with diazepam thrice daily in anxiety
- PMID: 20284
Clorazepate: double blind crossover comparison of a single nightly dose with diazepam thrice daily in anxiety
Abstract
In a double blind cross-over study in 40 patients with mild to moderate anxiety, clorazepate 15 mg at bedtime was as effective as diazepam on global rating and slightly superior on target symptom assessment. There was a significantly higher incidence and frequency of side effects during diazepam treatment. Occurrence of side effect related to plasma diazepam, and anxiolytic effect related to plasma nordiazepam. These results are discussed in relation to convenience of the single dose regimen and psychomotor performance.